Advance your academic career, collaborate globally, and expand your network— join now !

Dr. Tanya Camacho

Share Link

Share

Information

Tanya Amanda Camacho-Villegas is a researcher for Mexico in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., located in Guadalajara, Jalisco, Mexico (2014-present). She is a member of the Mexican National System of Researchers, level I. She works in recombinant protein design, cloning, and production (batch and bioreactor scale). She specializes in phage display for the isolation of single-domain antibodies such as vNARs or peptide isolation with diagnostic applications. Recently, she used the vNAR as an immuno-carrier for NPs for theranostics applications for breast cancer and glioblastomas as models. She has received a BSc in Biology from the Science Faculty, UABC (2004) and a Marine Biotechnology MSc in CICESE (2007), focusing on the selection and validation of vNARs with anti-cytokines properties as candidates for TNFalpha and VEGF165 neutralizing in human disorders. She has received a PhD in Molecular Ecology and Biotechnology from the Marine Science Faculty at UABC (2012). She received a distinction in the PhD dissertation and fellowships from CONACYT for MSc, PhD, and postdoc studies. She was the leader of four projects related to biotechnology companies. She was the author of patents related to vNAR as anti-cytokines or immuno-carriers for drug delivery.

Short Biography

Tanya Amanda Camacho-Villegas is a researcher for Mexico in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., located in Guadalajara, Jalisco, Mexico (2014-present). She is a member of the Mexican National System of Researchers, level I. She works in recombinant protein design, cloning, and production (batch and bioreactor scale). She specializes in phage display for the isolation of single-domain antibodies such as vNARs or peptide isolation with diagnostic applications. Recently, she used the vNAR as an immuno-carrier for NPs for theranostics applications for breast cancer and glioblastomas as models. She has received a BSc in Biology from the Science Faculty, UABC (2004) and a Marine Biotechnology MSc in CICESE (2007), focusing on the selection and validation of vNARs with anti-cytokines properties as candidates for TNFalpha and VEGF165 neutralizing in human disorders. She has received a PhD in Molecular Ecology and Biotechnology from the Marine Science Faculty at UABC (2012). She received a distinction in the PhD dissertation and fellowships from CONACYT for MSc, PhD, and postdoc studies. She was the leader of four projects related to biotechnology companies. She was the author of patents related to vNAR as anti-cytokines or immuno-carriers for drug delivery.